Res., 3, 113119
The only FDA-approved oral GLP-1, Rybelsus, required a specialized absorption enhancer called SNAC to achieve roughly 1% bioavailability, and even then must be taken under tightly controlled conditions
IV fluids rehydrate you rapidly, while high-dose vitamins help your cells function more efficiently and support natural immune responses
Sustainable weight loss occurs when medication supports behavior change, metabolic improvement, and long-term habits
Increased ATP/ADP ratio induces the closure of ATP-sensitive potassium (K ATP ) channels, leading to membrane depolarization followed by activation of voltage-gated Ca 2+ channels (VGCC) and Ca 2+ influx
readout expected Q2-Q3 2026) TRIUMPH-3 Obesity with established cardiovascular disease (readout expected late 2026) TRIUMPH-4 Obesity with knee osteoarthritis (reported Dec 2025: -28.7%) TRIUMPH-5 Obesity with metabolic-dysfunction-associated steatotic liver disease (MASLD) TRIUMPH-6 Obesity with chronic low back pain TRIUMPH-OSA Obesity with obstructive sleep apnea TRIUMPH-Outcomes (CVOT) 17,500-patient cardiovascular outcomes trial (readout 2027+) Plus the parallel TRANSCEND-T2D program for diabetes labels (TRANSCEND-T2D-1 reported March 2026)